Family Medicine · Fort Worth, TX
NPI
1194918649
Since 2007
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
654 Saint Louis Ave
Fort Worth, TX, 76104
Phone (817) 386-9818
Groups this clinician bills Medicare through
Medicare paid, 2024
$314K
5,200 services
Medicare patients, 2024
521
Average age 73
Drug cost, 2024
$3.4M
42,333 prescriptions
Company payments, 2025
$258
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Olawale O Akinmerese was code 99308 (snf e&m), 3,187 times for 268 patients. In total Olawale O Akinmerese billed 5,200 services in 15 codes, and Medicare paid $314K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-10-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99308 SNF E&M | Facility | 3,187 | 268 | $52.34 | $167K |
| 99309 SNF E&M | Facility | 1,021 | 240 | $72.93 | $74K |
| 99232 Hospital E&M - Subsequent | Facility | 650 | 155 | $55.40 | $36K |
| 99306 SNF E&M | Facility | 130 | 127 | $128.61 | $17K |
| 99214 Office E&M - Established | Office | 61 | 17 | $78.14 | $4,767 |
| 99223 Hospital E&M - Initial | Facility | 50 | 49 | $120.36 | $6,018 |
| 99222 Hospital E&M - Initial | Facility | 42 | 38 | $90.52 | $3,802 |
| 99305 SNF E&M | Facility | 41 | 40 | $94.22 | $3,863 |
By year: 2022 $268K for 4,449 services; 2023 $307K for 4,581 services; 2024 $314K for 5,200 services.
Medicare prescription drug claims, 2024
In 2024, the drug Olawale O Akinmerese prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,212 prescriptions and refills. In total Olawale O Akinmerese wrote 42,333 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,212 | 2,597 | 378 | $30K |
| Amlodipine Besylate Generic | 1,402 | 1,566 | 240 | $13K |
| Gabapentin Generic | 1,236 | 1,320 | 221 | $23K |
| Furosemide Generic | 1,144 | 1,203 | 202 | $8,231 |
| Potassium Chloride Generic | 1,140 | 1,168 | 203 | $25K |
| Eliquis Apixaban | 1,131 | 1,149 | 124 | $340K |
| Levothyroxine Sodium Generic | 786 | 857 | 121 | $11K |
| Tamsulosin Hcl Generic | 780 | 847 | 129 | $12K |
| Lisinopril Generic | 751 | 890 | 131 | $8,160 |
| Trazodone Hcl Generic | 749 | 781 | 124 | $9,432 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 742 | 742 | 107 | $23K |
| Metoprolol Tartrate Generic | 736 | 785 | 116 | $7,447 |
| Pantoprazole Sodium Generic | 728 | 852 | 176 | $11K |
| Sertraline Hcl Generic | 709 | 723 | 98 | $9,563 |
| Metformin Hcl Generic | 672 | 802 | 111 | $7,158 |
Brand drugs: 5,926 claims; generic drugs: 36,195 claims; opioid claims: 1,449.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Olawale O Akinmerese $258 ($258 in general payments such as food, travel and fees) from 8 companies. The largest payer was Otsuka America Pharmaceutical, Inc. with $62.
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $62 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 2 | $42.05 |
| Lundbeck LLC | 2 | $40.37 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $27 |
| SK Life Science, Inc. | 1 | $25.22 |
| Novo Nordisk Inc NVO | 1 | $20.63 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $20.56 |
| Lilly USA, LLC LLY | 1 | $20.3 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.